Meeting the Challenges of IBD Management in the Era of COVID-19: A Panel Case Review & Discussion

62-21-623-WC-001_IBD Phase 3_Concept_1200x600 (1)

Activity Overview

We have surveyed inflammatory bowel disease (IBD) providers around the country to find what cases they have struggled with when their patients with IBD concurrently developed COVID-19. In this activity, an IBD expert panel has been convened to discuss cases submitted by these physicians and answer questions such as, do biologics need to be interrupted? Do mRNA vaccines work when a patient is on a biologic? Do the COVID-19 vaccines cause IBD to flare? The panel takes on these timely questions and introduces you to a novel clinical decision support tool that you can access right now to help you assess your patients’ IBD complication risk and predict their response to biologics. The panel directly demonstrates how to utilize this free tool to manage IBD in these challenging cases, how your colleagues have been using it already, and how you can take advantage of it too.

0.50 CE Credit(s)
Expires: January 3, 2023

Target Audience

This activity is intended for gastroenterology clinicians (MD/DO/NP/PA) and primary care clinicians involved in the care of patients with inflammatory bowel disease (IBD).

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Stratify patients with inflammatory bowel disease (IBD) by disease severity and complication risk using predictive decision support tools
  • Implement personalized approaches to biologic therapies for patients with IBD based on probability of response to treatment
  • Identify patients with IBD at high risk of complications who may require treat-to-target monitoring or combination therapy

Activity Faculty

Dulai

Parambir Dulai, MD (Chair)

Assistant Professor
UC San Diego School of Medicine
La Jolla, CA

Faculty-Kochhar-300x400px (1)

Gursimran Singh Kochhar, MD, FACP, CNSC

Associate Chief Division, Gastroenterology, Hepatology & Nutrition
Medical Director, Endoscopic Innovations AHN
Assistant Professor of Medicine, Drexel University
Interventional IBD & Therapeutic Endoscopy
Allegheny Health Network
Pittsburgh, PA

Faculty-Ungaro-300x400px (1)

Ryan Ungaro, MD, MS

Assistant Professor
The Susan and Leonard Feinstein IBD Center
Dr. Henry D. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai
New York, NY